Nephros, Inc.
NEPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $15 | $36 | $12 | $59 |
| - Cash | $4 | $4 | $4 | $7 |
| + Debt | $1 | $2 | $1 | $1 |
| Enterprise Value | $13 | $33 | $9 | $53 |
| Revenue | $14 | $14 | $10 | $10 |
| % Growth | -0.5% | 42.7% | -2.4% | – |
| Gross Profit | $9 | $8 | $5 | $6 |
| % Margin | 61.6% | 59% | 47.4% | 55.1% |
| EBITDA | $0 | -$1 | -$4 | -$2 |
| % Margin | 1.6% | -9.5% | -37% | -24.4% |
| Net Income | $0 | -$2 | -$7 | -$4 |
| % Margin | 0.5% | -11.1% | -74% | -40.2% |
| EPS Diluted | 0.007 | -0.15 | -0.72 | -0.41 |
| % Growth | 104.7% | 79.2% | -75.6% | – |
| Operating Cash Flow | -$0 | $1 | -$3 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | $1 | -$3 | -$1 |